Dr. Jerome Adams Praises CDC Nominee Erica Schwartz, Warns of Kennedy Pressure
Jerome Adams called Erica Schwartz a "home run pick" but said Kennedy's HHS could push her toward "ideology over evidence."

Dr. Jerome Adams praised Erica Schwartz as a "home run pick" for the Centers for Disease Control and Prevention, but he also warned that the real test may come after confirmation, inside a Health and Human Services Department run by Robert F. Kennedy Jr.
Speaking on CBS News’ Face the Nation on Sunday, Adams said Schwartz is well-qualified, yet may face pressure to follow "ideology over evidence" if she takes over the Atlanta-based public health agency. The warning lands at a moment when the CDC has already been through months of instability under Kennedy’s leadership, including leadership shakeups and long stretches without a full-time political leader.
President Donald Trump nominated Schwartz on Thursday, April 16, 2026, to lead the CDC. Schwartz is a former deputy surgeon general and retired rear admiral in the U.S. Public Health Service Commissioned Corps, a résumé that has led several outlets to describe her as a more traditional or establishment choice rather than a figure tied to the Make America Healthy Again movement. She served as deputy surgeon general from January 2019 to April 2021.
Schwartz also brings a long record from the U.S. Coast Guard, where she served as chief medical officer and chief of health services. In that role, she oversaw a health system that included 41 clinics and 150 sick bays, a scale that underscores the operational demands she would face at CDC if the Senate approves her nomination.
The nomination arrives after a turbulent period for the agency. CDC’s leadership page says Jay Bhattacharya is performing the delegable duties of the CDC director, a sign that the agency remains without a permanent leader at the top. That vacuum followed the departure of Susan Monarez in August 2025, after clashes with Kennedy over vaccine policy intensified anxiety among public health officials about whether the agency’s science-based mission could withstand political pressure.
The CDC director post has also become more politically charged in recent years as Congress moved toward making the job Senate-confirmed, turning the next leader into both a public health administrator and a political test case. Schwartz will still need Senate approval, and Adams’ warning suggests the central question is not just whether she can run the agency, but whether she can keep its decisions anchored in evidence when the pressure to bend toward ideology is strongest.
Know something we missed? Have a correction or additional information?
Submit a Tip

